Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1623
| Despition | USH1C Human Recombinant |
| SIZE | 5 µg |
| Purity | > 95.0% (SDS-PAGE) |
| Form | Sterile Filtered colorless solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1299 | Calretinin Blocking Peptide (AC1299) | 250 µg | inquiry |
| ACPP-1440 | Human SIRPA Protein (AC1440) | 5 µg | inquiry |
| ACPP-1429 | Human FGF14 Protein (AC1429) | 2 µg | inquiry |
| ACPP-1817 | Human NT 4 Protein (AC1817) | 20 µg | inquiry |
| ACPP-1826 | Human CRYGN Protein (AC1826) | 5 µg | inquiry |
| ACPP-1334 | DRP1 Blocking Peptide (AC1334) | 250 µg | inquiry |
| ACPP-1730 | Human S100A8 Protein, His (AC1730) | 2 µg | inquiry |
| ACPP-1617 | Human PARK2 Protein (AC1617) | 5 µg | inquiry |
| ACPP-1476 | Human ENSA Protein (AC1476) | 5 µg | inquiry |
| ACPP-1385 | Human TGFBI Protein (AC1385) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.